Intraperitoneal atrial natriuretic peptide increases peritoneal fluid and solute removal.

BACKGROUND Atrial natriuretic peptide (ANP) is a hormone with well-known diuretic and vasodilating properties. Recently it was reported that ANP could increase the peritoneal fluid formation and increase peritoneal solute clearance. This study investigated the effect of ANP on peritoneal fluid and solute transport characteristics. METHODS Eighteen male Sprague-Dawley rats were divided into three groups. A four-hour dwell study using 25 mL 2.27% glucose dialysis solution with 50 microg/kg ANP (N = 6, H-ANP) or 5 microg/kg ANP (N = 6, L-ANP) or without ANP (N = 8, control) and frequent dialysate and blood sampling was done in each rat. Radiolabeled human albumin (RISA) was added to the solution as an intraperitoneal volume marker. RESULTS The intraperitoneal volume was significantly higher in the H-ANP group as compared with the control group and the L-ANP group. The drainage volume was 26.2 +/- 1.1, 25.5 +/- 0.7, and 29.8 +/- 0.8 mL for the control, L-ANP, and H-ANP groups, respectively (P < 0.01). This was related to significant differences in the peritoneal fluid absorption rates (K(E); estimated as the RISA elimination coefficient): 39 +/- 3, 38 +/- 3, and 19 +/- 4 microL/min, and in the direct lymphatic absorption rate (K(EB); estimated as the clearance of RISA from dialysate to blood): 7 +/- 1, 6 +/- 1, and 4 +/- 1 microL/min for the control, L-ANP, and H-ANP groups, respectively (all P < 0.01). No differences were found in the intraperitoneal volume, K(E), and K(EB) between the control group and the L-ANP group. The diffusive mass transport coefficient (K(BD)) for urea, sodium, potassium, and total protein did not differ among the three groups. However, the glucose D/D(0) was significantly higher, and the K(BD) for glucose was significantly lower in the H-ANP group as compared with the other two groups. Solute clearances (+175% for sodium and +26% for potassium) were significantly increased in the H-ANP group, mainly as a result of the increased fluid removal in this group. CONCLUSIONS Our results suggest that ANP may decrease peritoneal fluid absorption (by 51%, partially because of decreasing the direct lymphatic absorption), resulting in a significant increase in peritoneal fluid removal and small solute clearances. While the basic diffusive permeability of the peritoneal membrane was not changed, the peritoneal glucose absorption was retarded by adding ANP to peritoneal dialysate, perhaps through interaction of ANP with glucose metabolism.

[1]  J. Waniewski,et al.  Effect of increased dialysate fill volume on peritoneal fluid and solute transport. , 1997, Kidney international.

[2]  M. Vatta,et al.  Atrial natriuretic factor increases peritoneal dialysis efficiency in nephrectomized rats , 1996, Peptides.

[3]  C. Ronco Limitations of peritoneal dialysis. , 1996, Kidney international. Supplement.

[4]  R. Vanholder,et al.  Cardiovascular diseases in peritoneal dialysis patients: the size of the problem. , 1996, Kidney international. Supplement.

[5]  O. Heimbürger Residual renal function, peritoneal transport characteristics and dialysis adequacy in peritoneal dialysis. , 1996, Kidney international. Supplement.

[6]  D. Churchill,et al.  Recommended Clinical Practices for Maximizing Peritoneal Dialysis Clearances , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[7]  J. Waniewski,et al.  Diffusive mass transport coefficients are not constant during a single exchange in continuous ambulatory peritoneal dialysis. , 1996, ASAIO journal.

[8]  M. Flessner,et al.  Pressure threshold for fluid loss from the peritoneal cavity. , 1996, The American journal of physiology.

[9]  S. Davies,et al.  The Predictive Value of Kt/V and Peritoneal Solute Transport in Capd Patients is Dependent on the Type of Comorbidity Present , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  J. Waniewski,et al.  Paradoxes in Peritoneal Transport of Small Solutes , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  J. Waniewski,et al.  Lyphatic absorption in CAPD patients with loss of ultrafiltration capacity. , 1995, Blood purification.

[12]  J. Heaf CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate. , 1995, Renal failure.

[13]  B. Rippe,et al.  Intraperitoneal fluid volume changes during peritoneal dialysis in the rat: indicator dilution vs. volumetric measurements. , 1995, Blood purification.

[14]  B. Rippe,et al.  Peritoneal Fluid and Tracer Albumin Kinetics in the Rat. Effects of Increases in Intraperitoneal Hydrostatic Pressure , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  B. Teehan,et al.  Adequacy of continuous ambulatory peritoneal dialysis: morbidity and mortality in chronic peritoneal dialysis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  J. Waniewski,et al.  Bidirectional Solute Transport in Peritoneal Dialysis , 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[17]  J. Waniewski,et al.  Methods for Estimation of Peritoneal Dialysate Volume and Reabsorption Rate Using Macromolecular Markers , 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[18]  N. Perico,et al.  Edema of the nephrotic syndrome: the role of the atrial peptide system. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  G. Christensen,et al.  Atrial natriuretic factor increases peritoneal fluid formation in the pig. , 1993, Acta physiologica Scandinavica.

[20]  P. Hirszel,et al.  Learning Peritoneal Physiology by Pharmacological Manipulation a , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[21]  J. Díaz-Buxó Is continuous ambulatory peritoneal dialysis adequate long-term therapy for end-stage renal disease? A critical assessment. , 1992, Journal of the American Society of Nephrology : JASN.

[22]  J. Waniewski,et al.  Simple Membrane Models for Peritoneal Dialysis Evaluation of Diffusive and Convective Solute Transport , 1992, ASAIO journal.

[23]  J. Waniewski,et al.  A quantitative description of solute and fluid transport during peritoneal dialysis. , 1992, Kidney international.

[24]  J. Brandes,et al.  Clinical outcome of continuous ambulatory peritoneal dialysis predicted by urea and creatinine kinetics. , 1992, Journal of the American Society of Nephrology : JASN.

[25]  M. Currie,et al.  Atrial natriuretic peptide inhibits oxidant-induced increases in endothelial permeability. , 1991, Journal of molecular and cellular cardiology.

[26]  M. Flessner,et al.  Peritoneal transport physiology: insights from basic research. , 1991, Journal of the American Society of Nephrology : JASN.

[27]  B. Brenner,et al.  Diverse biological actions of atrial natriuretic peptide. , 1990, Physiological reviews.

[28]  M. Kadekaro,et al.  Atriopeptin prevents angiotensin II-stimulated glucose utilization in the subfornical organ , 1990, Peptides.

[29]  A. Cowley,et al.  Atrial natriuretic peptide augments forearm capillary filtration in humans. , 1990, The American journal of physiology.

[30]  R. Mactier Measurement of Dialysate Volumes in Peritoneal Dialysis , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[31]  N. Trippodo,et al.  Atrial natriuretic factor decreases whole-body capillary absorption in rats. , 1987, The American journal of physiology.

[32]  V. Huxley,et al.  Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. , 1987, Circulation research.

[33]  T. Maack,et al.  Atrial natriuretic factor increases hematocrit and decreases plasma volume in nephrectomized rats. , 1986, Life sciences.

[34]  A. Karara,et al.  Inhibition of water-sodium intestinal absorption by an atrial extract. , 1986, Canadian journal of physiology and pharmacology.

[35]  B. Leibel,et al.  Plasma Amino Acid Profiles and Amino Acid Losses in Patients Undergoing CAPD , 1981 .

[36]  J. Waniewski,et al.  Daily exposure to dialysis fluid results in changes in peritoneal transport. , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[37]  J. Waniewski,et al.  Time dependence of solute removal during a single exchange. , 1997, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[38]  R. Gokal,et al.  Does CAPD provide adequate dialysis? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  B. Rippe,et al.  Peritoneal physiology-transport of solutes , 1994 .

[40]  J. Leypoldt,et al.  Ultrafiltration in peritoneal dialysis , 1994 .

[41]  N. Lameire,et al.  Pharmacologic alterations of peritoneal transport rates and pharmacokinetics of the peritoneum , 1994 .

[42]  L. Gotloib,et al.  Lessons of peritoneal ultrastructure: from an inert dialyzing sheet to a living membrane. , 1992, Contributions to nephrology.

[43]  J. Waniewski,et al.  Aqueous solute concentrations and evaluation of mass transport coefficients in peritoneal dialysis. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  K. Nolph,et al.  Pharmacological alteration of ultrafiltration. , 1990, Contributions to nephrology.